SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
开心的QQ熊
Lv7
3310 积分
2022-05-23 加入
最近求助
最近应助
互助留言
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
2天前
已完结
Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study
2天前
已完结
Randomized Trial of Irinotecan and Cetuximab With or Without Vemurafenib in BRAF-Mutant Metastatic Colorectal Cancer (SWOG S1406)
3天前
已完结
HERTHENA-Lung02: phase III study of patritumab deruxtecan in advanced EGFR-mutated NSCLC after a third-generation EGFR TKI
29天前
已完结
The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer
1个月前
已完结
Evaluation of short ⁃term (16⁃week)effectiveness and safety of guselkumab in patients with psoriasis: a prospective real ⁃ life study on the Chinese population
1个月前
已完结
Bimekizumab for the treatment of psoriasis
1个月前
已完结
Long ⁃term efficacy and safety of brodalumab in the treatment of psoriasis: 120 ⁃ week results from the randomized, double⁃blind, placebo⁃ and active comparator ⁃ controlled phase 3 AMAGINE ⁃ 2 trial
1个月前
已完结
Phase 3 studies comparing brodalumab with ustekinumab in psoriasis
1个月前
已完结
Efficacy and safety of ixekizumab in Chinese patients with moderate ⁃to ⁃ severe plaque psoriasis: 60 ⁃ week results from a phase 3 study
1个月前
已完结
没有进行任何应助
速度真快,感谢
2天前
速度真快,感谢
2天前
速度真快,感谢
3天前
速度真快,感谢
29天前
速度真快,感谢
1个月前
速度真快,感谢
1个月前
速度真快,感谢
1个月前
速度真快,感谢
1个月前
速度真快,感谢
1个月前
速度真快,感谢
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论